Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Superantigens: supersignalers?

Rose Zamoyska1

  • 1Molecular Immunology, Medical Research Council National Institute for Medical Research, The Ridgeway, Mill Hill, London NW7 4RD, UK. rzamoys@nimr.mrc.ac.uk

Science'S STKE : Signal Transduction Knowledge Environment
|October 26, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CD8 T lymphocytes deploy embryonic cell cycle control mechanisms for rapid cell proliferation.

EMBO reports·2026
Same author

OT-I TCR Transgenic Mice to Study the Role of PTPN22 in Anti-cancer Immunity.

Methods in molecular biology (Clifton, N.J.)·2023
Same author

Deletion of the protein tyrosine phosphatase PTPN22 for adoptive T cell therapy facilitates CTL effector function but promotes T cell exhaustion.

Journal for immunotherapy of cancer·2023
Same author

miR-7 is recruited to the high molecular weight RNA-induced silencing complex in CD8<sup>+</sup> T cells upon activation and suppresses IL-2 signaling.

RNA (New York, N.Y.)·2023
Same author

Translation factor eIF5a is essential for IFNγ production and cell cycle regulation in primary CD8<sup>+</sup> T lymphocytes.

Nature communications·2022
Same author

Construction of a T cell receptor signaling range for spontaneous development of autoimmune disease.

The Journal of experimental medicine·2022
Same journal

Identification of redox-active cell-surface proteins by mechanism-based kinetic trapping.

Science's STKE : signal transduction knowledge environment·2007
Same journal

Image correlation spectroscopy.

Science's STKE : signal transduction knowledge environment·2007
Same journal

Studies of SARM1 uncover similarities between immune and neuronal responses to danger.

Science's STKE : signal transduction knowledge environment·2007
Same journal

A discrete signaling function for an inositol pyrophosphate.

Science's STKE : signal transduction knowledge environment·2007
Same journal

Putting on the RITz.

Science's STKE : signal transduction knowledge environment·2007
Same journal

Type I interferons as anti-inflammatory mediators.

Science's STKE : signal transduction knowledge environment·2007
See all related articles

Superantigens (SAgs) trigger massive T cell activation through a novel pathway involving Galpha(11) and phospholipase C-beta (PLC-beta), distinct from conventional antigen signaling. This discovery offers new therapeutic targets for SAg-mediated diseases.

Area of Science:

  • Immunology
  • Molecular Biology
  • Cell Signaling

Background:

  • Superantigens (SAgs) are potent immune activators from bacteria and viruses, causing massive T cell activation and severe conditions like toxic shock.
  • SAgs bind promiscuously to MHC class II and TCR, activating T cells differently than conventional peptide antigens.
  • Previously, SAg-induced T cell activation was assumed to follow the canonical TCR signaling pathway.

Purpose of the Study:

  • To investigate the distinct signaling pathways utilized by superantigens (SAgs) in T cell activation.
  • To identify the specific molecular players involved in SAg-mediated T cell signaling beyond the canonical pathway.

Main Methods:

  • Investigated T cell activation by SAgs in the absence of Lck (a Src family kinase).
  • Focused on the role of heterotrimeric guanine nucleotide-binding proteins (G proteins), specifically Galpha(11).

Related Experiment Videos

  • Examined the activation of phospholipase C-beta (PLC-beta) and its downstream signaling.

    • Main Results:

    • Demonstrated that SAgs can stimulate T cells independently of Lck.
    • Identified Galpha(11) as a key mediator in SAg-induced T cell activation.
    • Showed that Galpha(11) activates PLC-beta, linking SAgs to phosphatidylinositol and protein kinase C signaling pathways.

    Conclusions:

    • SAgs activate a unique signaling pathway in T cells, distinct from that of conventional peptide antigens.
    • This alternative pathway involves Galpha(11) and PLC-beta, bypassing Lck.
    • The identification of this SAg-specific pathway opens avenues for developing targeted therapies against SAg-induced diseases.